The President issues a Presidential Decree on the procurement, distribution, implementation of the Covid vaccine, this is the contents

ILLUSTRATION. President Joko Widodo issued a Presidential Decree on the procurement, distribution and implementation of the Covid-19 vaccine. This is the contents.

Reporter: Titis Nurdiana | Editor: Titis Nurdiana

KONTAN.CO.ID -JAKARTA. President Joko Widodo issued Presidential Regulation (Perpres) No. 99/2020 concerning Vaccines Procurement and Implementation of Vaccinations in the Context of the 2019 Corona Virus Disease Pandemic (Covid-19).

In the Presidential Decree, which Jokowi signed on October 5, the government regulates procurement, vaccination and distribution of the Covid-19 vaccine.

“The procurement for the Covid-19 vaccine and the implementation of the Covid-19 vaccination as referred to in paragraph (1) shall be carried out for 2020, 2021, and 2022,” wrote the rules mentioned in article 2 paragraph 4.

The vaccination time can be extended by the Committee for Handling COVID-19 and National Economic Recovery based on a recommendation from the Minister of Health.

Article 2 paragraph 6 states that the government prioritizes the procurement of the COVID-19 vaccine from within the country.

Also Read: Minister of Health: Prioritized vaccines for medical personnel and workers aged 18-59 years

The parties that can procure vaccines are BUMN. The BUMN that has been assigned is PT Bio Farma (Persero), the Minister of Health and may involve subsidiaries such as PT Bio Farma (Persero), namely PT Kimia Farma Tbk and PT IndofarmaTbk.

Meanwhile international institutions / agencies that can participate in offering or collaborating on research, production and / or provision of the COVID-19 vaccine are

(a) The Coalition for Epidemic Preparedness Innovations (CEPI);

(b) The Global Alliance for Vaccines and Immunizations (GAVI);

and / or (c.) other international institutions / agencies.

The price of vaccines is set by the minister of health. “The Minister of Health sets the purchase price for the Covid-19 vaccine by taking into account the emergency and limited availability of the Covid-19 vaccine.

Meanwhile, the Ministry of Health will continue to carry out the COVID-19 vaccination. The Ministry of Health in the implementation of vaccination has the authority to determine: Criteria and priorities for vaccine recipients; Priority recipient areas for vaccines; Schedule and stages of vaccine administration; as well as the standard of vaccination services (Article 13 paragraph 2).

The vaccine procurement process is carried out by the state-owned company PT Bio Farma (Persero). In the process, Bio Farma collaborates with domestic and international business entities or institutions by the Ministry of Foreign Affairs after coordinating with the Ministry of Health.

The Perpres also regulates the authority of the Minister of Health in setting the purchase price for the covid-19 vaccine.

“The Minister of Health sets the purchase price for the covid-19 vaccine by taking into account the emergency and limited availability of the covid-19 vaccine,” the regulation said, as quoted in a copy of the Presidential Decree, Wednesday (7/10).

Also Read: The price of the Sinovac Bio Farma vaccine is IDR 200 thousand per dose, targeting 185.95 million people

The purchase price for the covid-19 vaccine is carried out in accordance with good governance, accountability, and there is no conflict of interest.

When it happens major force or force majeure, cooperation in providing the covid-19 vaccine can be stopped. This force majeure is a condition when there is an incident against the will of what is agreed in the contract.

Then the process of vaccination is also carried out by the Ministry of Health. Later, the Ministry of Health is required to determine the criteria and priorities for vaccine recipients, priority areas for vaccine recipients, schedule and stages of vaccine administration, and standard of vaccination services.

Jokowi previously targeted a vaccine to be available soon by the end of 2020.

The government itself continues to develop vaccines both independently and in collaboration with a Chinese company, Sinovac, which is conducting trials of the third phase of the Covid-19 vaccine.

In addition, there are also PT Kimia Farma (Persero) and PT Indo Farma (Persero) with a health technology company from the United Arab Emirates, G42. Independently, Indonesia is also developing a vaccine through the Eijkman Institute for Molecular Biology.

Also Read: Masks are the main weapon against Covid-19

#Covid-19 task force #ingatpesanibu #pakaimasker #jagajarak #shareddistributorcollection egg #cucitangan #cucitanganpakaisabun

DONATION, Get Free Vouchers!

Your support will increase our enthusiasm to present quality and useful articles.

As an expression of gratitude for your attention, there are free vouchers worth donations that can be used shopping at HAPPY STORE.



Video Pilihan

–> <!–


Reporter: Titis Nurdiana
Editor: Titis Nurdiana





Share on facebook
Share on pinterest
Share on twitter
Share on linkedin
Share on email


Leave a Reply

Your email address will not be published. Required fields are marked *

This site uses Akismet to reduce spam. Learn how your comment data is processed.